Ocular Drug Delivery Technology Market (Technology: Topical, Ocular Insert, Iontophoresis, Intraocular Implant, In Situ Gel & Punctal Plug, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

Ocular Drug Delivery Technology Market (Technology: Topical, Ocular Insert, Iontophoresis, Intraocular Implant, In Situ Gel & Punctal Plug, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034


Ocular Drug Delivery Technology Market – Scope of Report

TMR’s report on the global ocular drug delivery technology market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global ocular drug delivery technology market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global ocular drug delivery technology market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the ocular drug delivery technology market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global ocular drug delivery technology market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global ocular drug delivery technology market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global ocular drug delivery technology market.

The report delves into the competitive landscape of the global ocular drug delivery technology market. Key players operating in the global ocular drug delivery technology market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global ocular drug delivery technology market profiled in this report.

Key Questions Answered in Global ocular drug delivery technology Market Report
  • What is the sales/revenue generated by ocular drug delivery technology across all regions during the forecast period?
  • What are the opportunities in the global ocular drug delivery technology market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Ocular Drug Delivery Technology Market – Research Objectives and Research Approach

The comprehensive report on the global ocular drug delivery technology market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global ocular drug delivery technology market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global ocular drug delivery technology market.


1. Preface
  1.1. Market Definition and Scope
  1.2. Market Segmentation
  1.3. Key Research Objectives
  1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Ocular Drug Delivery Technology Market
4. Market Overview
  4.1. Introduction
  4.1.1. Product Definition
  4.1.2. Industry Evolution / Developments
  4.2. Overview
  4.3. Market Dynamics
  4.3.1. Drivers
  4.3.2. Restraints
  4.3.3. Opportunities
  4.4. Global Ocular Drug Delivery Technology Market Analysis and Forecast, 2020-2034
5. Key Insights
  5.1. Pipeline Analysis
  5.2. Key Product/Brand Analysis
  5.3. Key Mergers & Acquisitions
  5.4. COVID-19 Pandemic Impact on Industry
6. Global Ocular Drug Delivery Technology Market Analysis and Forecast, by Technology
  6.1. Introduction and Definitions
  6.2. Key Findings/Developments
  6.3. Market Value Forecast, by Technology, 2020-2034
  6.3.1. Topical
  6.3.2. Ocular Insert
  6.3.2.1. Erodible
  6.3.2.2. Non-erodible
  6.3.3. Iontophoresis
  6.3.4. Intraocular Implant
  6.3.4.1. Biodegradable
  6.3.4.2. Non-biodegradable
  6.3.5. In Situ Gel & Punctal Plug
  6.3.6. Others
  6.4. Market Attractiveness, by Technology
7. Global Ocular Drug Delivery Technology Market Analysis and Forecast, by Formulation Type
  7.1. Introduction and Definitions
  7.2. Key Findings/Developments
  7.3. Market Value Forecast, by Formulation Type, 2020-2034
  7.3.1. Solution
  7.3.2. Suspension
  7.3.3. Emulsion
  7.3.4. Liposome & Nanoparticle
  7.3.5. Ointment
  7.4. Market Attractiveness, by Formulation Type
8. Global Ocular Drug Delivery Technology Market Analysis and Forecast, by Disease Type
  8.1. Introduction and Definitions
  8.2. Key Findings/Developments
  8.3. Market Value Forecast, by Disease Type, 2020-2034
  8.3.1. Glaucoma
  8.3.2. Macular Degeneration
  8.3.3. Diabetic Retinopathy
  8.3.4. Cataract
  8.3.5. Diabetic Macular Edema
  8.3.6. Dry Eye Syndrome
  8.3.7. Others
  8.4. Market Attractiveness, by Disease Type
9. Global Ocular Drug Delivery Technology Market Analysis and Forecast, by End-user
  9.1. Introduction and Definitions
  9.2. Key Findings/Developments
  9.3. Market Value Forecast, by End-user, 2020-2034
  9.3.1. Hospitals
  9.3.2. Ambulatory Surgical Centers
  9.3.3. Ophthalmic Clinics
  9.3.4. Homecare Settings
  9.4. Market Attractiveness, by End-user
10. Global Ocular Drug Delivery Technology Market Analysis and Forecast, by Region
  10.1. Key Findings
  10.2. Market Value Forecast, by Region, 2020-2034
  10.2.1. North America
  10.2.2. Europe
  10.2.3. Asia Pacific
  10.2.4. Latin America
  10.2.5. Middle East & Africa
  10.3. Market Attractiveness, by Region
11. North America Ocular Drug Delivery Technology Market Analysis and Forecast
  11.1. Introduction
  11.1.1. Key Findings
  11.2. Market Value Forecast, by Technology, 2020-2034
  11.2.1. Topical
  11.2.2. Ocular Insert
  11.2.2.1. Erodible
  11.2.2.2. Non-erodible
  11.2.3. Iontophoresis
  11.2.4. Intraocular Implant
  11.2.4.1. Biodegradable
  11.2.4.2. Non-biodegradable
  11.2.5. In Situ Gel & Punctal Plug
  11.2.6. Others
  11.3. Market Attractiveness, by Technology
  11.4. Market Value Forecast, by Formulation Type, 2020-2034
  11.4.1. Solution
  11.4.2. Suspension
  11.4.3. Emulsion
  11.4.4. Liposome & Nanoparticle
  11.4.5. Ointment
  11.5. Market Attractiveness, by Formulation Type
  11.6. Market Value Forecast, by Disease Type, 2020-2034
  11.6.1. Glaucoma
  11.6.2. Macular Degeneration
  11.6.3. Diabetic Retinopathy
  11.6.4. Cataract
  11.6.5. Diabetic Macular Edema
  11.6.6. Dry Eye Syndrome
  11.6.7. Others
  11.7. Market Attractiveness, by Disease Type
  11.8. Market Value Forecast, by End-user, 2020-2034
  11.8.1. Hospitals
  11.8.2. Ambulatory Surgical Centers
  11.8.3. Ophthalmic Clinics
  11.8.4. Homecare Settings
  11.9. Market Attractiveness, by End-user
  11.10. Market Value Forecast, by Country, 2020-2034
  11.10.1. U.S.
  11.10.2. Canada
  11.11. Market Attractiveness Analysis
  11.11.1. By Technology
  11.11.2. By Formulation Type
  11.11.3. By Disease Type
  11.11.4. By End-user
  11.11.5. By Country
12. Europe Ocular Drug Delivery Technology Market Analysis and Forecast
  12.1. Introduction
  12.1.1. Key Findings
  12.2. Market Value Forecast, by Technology, 2020-2034
  12.2.1. Topical
  12.2.2. Ocular Insert
  12.2.2.1. Erodible
  12.2.2.2. Non-erodible
  12.2.3. Iontophoresis
  12.2.4. Intraocular Implant
  12.2.4.1. Biodegradable
  12.2.4.2. Non-biodegradable
  12.2.5. In Situ Gel & Punctal Plug
  12.2.6. Others
  12.3. Market Attractiveness, by Technology
  12.4. Market Value Forecast, by Formulation Type, 2020-2034
  12.4.1. Solution
  12.4.2. Suspension
  12.4.3. Emulsion
  12.4.4. Liposome & Nanoparticle
  12.4.5. Ointment
  12.5. Market Attractiveness, by Formulation Type
  12.6. Market Value Forecast, by Disease Type, 2020-2034
  12.6.1. Glaucoma
  12.6.2. Macular Degeneration
  12.6.3. Diabetic Retinopathy
  12.6.4. Cataract
  12.6.5. Diabetic Macular Edema
  12.6.6. Dry Eye Syndrome
  12.6.7. Others
  12.7. Market Attractiveness, by Disease Type
  12.8. Market Value Forecast, by End-user, 2020-2034
  12.8.1. Hospitals
  12.8.2. Ambulatory Surgical Centers
  12.8.3. Ophthalmic Clinics
  12.8.4. Homecare Settings
  12.9. Market Attractiveness, by End-user
  12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
  12.10.1. Germany
  12.10.2. U.K.
  12.10.3. France
  12.10.4. Italy
  12.10.5. Spain
  12.10.6. Rest of Europe
  12.11. Market Attractiveness Analysis
  12.11.1. By Technology
  12.11.2. By Formulation Type
  12.11.3. By Disease Type
  12.11.4. By End-user
  12.11.5. By Country/Sub-region
13. Asia Pacific Ocular Drug Delivery Technology Market Analysis and Forecast
  13.1. Introduction
  13.1.1. Key Findings
  13.2. Market Value Forecast, by Technology, 2020-2034
  13.2.1. Topical
  13.2.2. Ocular Insert
  13.2.2.1. Erodible
  13.2.2.2. Non-erodible
  13.2.3. Iontophoresis
  13.2.4. Intraocular Implant
  13.2.4.1. Biodegradable
  13.2.4.2. Non-biodegradable
  13.2.5. In Situ Gel & Punctal Plug
  13.2.6. Others
  13.3. Market Attractiveness, by Technology
  13.4. Market Value Forecast, by Formulation Type, 2020-2034
  13.4.1. Solution
  13.4.2. Suspension
  13.4.3. Emulsion
  13.4.4. Liposome & Nanoparticle
  13.4.5. Ointment
  13.5. Market Attractiveness, by Formulation Type
  13.6. Market Value Forecast, by Disease Type, 2020-2034
  13.6.1. Glaucoma
  13.6.2. Macular Degeneration
  13.6.3. Diabetic Retinopathy
  13.6.4. Cataract
  13.6.5. Diabetic Macular Edema
  13.6.6. Dry Eye Syndrome
  13.6.7. Others
  13.7. Market Attractiveness, by Disease Type
  13.8. Market Value Forecast, by End-user, 2020-2034
  13.8.1. Hospitals
  13.8.2. Ambulatory Surgical Centers
  13.8.3. Ophthalmic Clinics
  13.8.4. Homecare Settings
  13.9. Market Attractiveness, by End-user
  13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
  13.10.1. China
  13.10.2. Japan
  13.10.3. India
  13.10.4. Australia & New Zealand
  13.10.5. Rest of Asia Pacific
  13.11. Market Attractiveness Analysis
  13.11.1. By Technology
  13.11.2. By Formulation Type
  13.11.3. By Disease Type
  13.11.4. By End-user
  13.11.5. By Country/Sub-region
14. Latin America Ocular Drug Delivery Technology Market Analysis and Forecast
  14.1. Introduction
  14.1.1. Key Findings
  14.2. Market Value Forecast, by Technology, 2020-2034
  14.2.1. Topical
  14.2.2. Ocular Insert
  14.2.2.1. Erodible
  14.2.2.2. Non-erodible
  14.2.3. Iontophoresis
  14.2.4. Intraocular Implant
  14.2.4.1. Biodegradable
  14.2.4.2. Non-biodegradable
  14.2.5. In Situ Gel & Punctal Plug
  14.2.6. Others
  14.3. Market Attractiveness, by Technology
  14.4. Market Value Forecast, by Formulation Type, 2020-2034
  14.4.1. Solution
  14.4.2. Suspension
  14.4.3. Emulsion
  14.4.4. Liposome & Nanoparticle
  14.4.5. Ointment
  14.5. Market Attractiveness, by Formulation Type
  14.6. Market Value Forecast, by Disease Type, 2020-2034
  14.6.1. Glaucoma
  14.6.2. Macular Degeneration
  14.6.3. Diabetic Retinopathy
  14.6.4. Cataract
  14.6.5. Diabetic Macular Edema
  14.6.6. Dry Eye Syndrome
  14.6.7. Others
  14.7. Market Attractiveness, by Disease Type
  14.8. Market Value Forecast, by End-user, 2020-2034
  14.8.1. Hospitals
  14.8.2. Ambulatory Surgical Centers
  14.8.3. Ophthalmic Clinics
  14.8.4. Homecare Settings
  14.9. Market Attractiveness, by End-user
  14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
  14.10.1. Brazil
  14.10.2. Mexico
  14.10.3. Rest of Latin America
  14.11. Market Attractiveness Analysis
  14.11.1. By Technology
  14.11.2. By Formulation Type
  14.11.3. By Disease Type
  14.11.4. By End-user
  14.11.5. By Country/Sub-region
15. Middle East & Africa Ocular Drug Delivery Technology Market Analysis and Forecast
  15.1. Introduction
  15.1.1. Key Findings
  15.2. Market Value Forecast, by Technology, 2020-2034
  15.2.1. Topical
  15.2.2. Ocular Insert
  15.2.2.1. Erodible
  15.2.2.2. Non-erodible
  15.2.3. Iontophoresis
  15.2.4. Intraocular Implant
  15.2.4.1. Biodegradable
  15.2.4.2. Non-biodegradable
  15.2.5. In Situ Gel & Punctal Plug
  15.2.6. Others
  15.3. Market Attractiveness, by Technology
  15.4. Market Value Forecast, by Formulation Type, 2020-2034
  15.4.1. Solution
  15.4.2. Suspension
  15.4.3. Emulsion
  15.4.4. Liposome & Nanoparticle
  15.4.5. Ointment
  15.5. Market Attractiveness, by Formulation Type
  15.6. Market Value Forecast, by Disease Type, 2020-2034
  15.6.1. Glaucoma
  15.6.2. Macular Degeneration
  15.6.3. Diabetic Retinopathy
  15.6.4. Cataract
  15.6.5. Diabetic Macular Edema
  15.6.6. Dry Eye Syndrome
  15.6.7. Others
  15.7. Market Attractiveness, by Disease Type
  15.8. Market Value Forecast, by End-user, 2020-2034
  15.8.1. Hospitals
  15.8.2. Ambulatory Surgical Centers
  15.8.3. Ophthalmic Clinics
  15.8.4. Homecare Settings
  15.9. Market Attractiveness, by End-user
  15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
  15.10.1. GCC Countries
  15.10.2. South Africa
  15.10.3. Rest of Middle East & Africa
  15.11. Market Attractiveness Analysis
  15.11.1. By Technology
  15.11.2. By Formulation Type
  15.11.3. By Disease Type
  15.11.4. By End-user
  15.11.5. By Country/Sub-region
16. Competition Landscape
  16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  16.2. Market Share Analysis, by Company (2023)
  16.3. Company Profiles
  16.3.1. Ocular Therapeutix, Inc.
  16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
  16.3.1.2. Product Portfolio
  16.3.1.3. Financial Overview
  16.3.1.4. SWOT Analysis
  16.3.1.5. Strategic Overview
  16.3.2. Alimera Sciences Inc.
  16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
  16.3.2.2. Product Portfolio
  16.3.2.3. Financial Overview
  16.3.2.4. SWOT Analysis
  16.3.2.5. Strategic Overview
  16.3.3. Allergan (an AbbVie company)
  16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
  16.3.3.2. Product Portfolio
  16.3.3.3. Financial Overview
  16.3.3.4. SWOT Analysis
  16.3.3.5. Strategic Overview
  16.3.4. Bausch Health Companies Inc.
  16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
  16.3.4.2. Product Portfolio
  16.3.4.3. Financial Overview
  16.3.4.4. SWOT Analysis
  16.3.4.5. Strategic Overview
  16.3.5. EyeGate Pharmaceuticals, Inc.
  16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
  16.3.5.2. Product Portfolio
  16.3.5.3. Financial Overview
  16.3.5.4. SWOT Analysis
  16.3.5.5. Strategic Overview
  16.3.6. Envisia Therapeutics Inc.
  16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
  16.3.6.2. Product Portfolio
  16.3.6.3. Financial Overview
  16.3.6.4. SWOT Analysis
  16.3.6.5. Strategic Overview
  16.3.7. Clearside Biomedical, Inc.
  16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
  16.3.7.2. Product Portfolio
  16.3.7.3. Financial Overview
  16.3.7.4. SWOT Analysis
  16.3.7.5. Strategic Overview
  16.3.8. Graybug Vision, Inc.
  16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
  16.3.8.2. Product Portfolio
  16.3.8.3. Financial Overview
  16.3.8.4. SWOT Analysis
  16.3.8.5. Strategic Overview
  16.3.9. Santen Pharmaceutical Co., Ltd.
  16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
  16.3.9.2. Product Portfolio
  16.3.9.3. Financial Overview
  16.3.9.4. SWOT Analysis
  16.3.9.5. Strategic Overview
  16.3.10. Taiwan Liposome Company, Ltd.
  16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
  16.3.10.2. Product Portfolio
  16.3.10.3. Financial Overview
  16.3.10.4. SWOT Analysis
  16.3.10.5. Strategic Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings